Reluctant to move after Oclacitinib (Apoquel) in dogs
117 reports to the FDA describe reluctant to move in dogs given Oclacitinib. That is 0.4% of all reports for this medicine, compared with 0.5% across reports for all dog medicines.
117Reports
40%Marked serious
23%Recovered
19%Died or euthanised
2 daysTypical onset
Sponsored
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Oclacitinib controls itching from allergies (tablet, a JAK inhibitor).
Products with this ingredient include Apoquel. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Questions owners ask
- Can Oclacitinib cause reluctant to move in dogs?
- 117 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 2 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Reluctant to move with similar medicines
- Reluctant to move after Cyclosporine (Atopica) 72 reports · 0.5% of its reports
All reported side effects of Oclacitinib in dogs · Medicines most reported with reluctant to move